CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer

Monday, February 1, 2021 1 min read

Key Takeaway: CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer

Full Press Release Details

CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial Officer.